VIA (Visual inspection with acetic acid) and VILI (Visual inspection with lugol’s iodine) as an initial approach with colposcopy as a next screening tool with its positive predictive value in low socioeconomic patients

Authors

  • Anita Paswan Department of Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
  • Anil Kumar Department of General Surgery, All India Institute of Medical Sciences, Patna, Bihar, India
  • Kumudini Jha Department of Obstetrics and Gynecology, Darbhanga Medical College and Hospital, Darbhanga, Bihar, India
  • Shail Kumari Sinha Department of Obstetrics and Gynecology, Darbhanga Medical College and Hospital, Darbhanga, Bihar, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20175847

Keywords:

Colposcopy, Cervical Cancer, Lugol’s Iodine, Low socioeconomic, VIA, VILI

Abstract

Background: Cervical Cancer is the second most common cancer in women worldwide and India alone contribute the 1/4th of the world’s cases of cervical cancer. In view to this huge burden there was need to establish a feasible screening programme to detect cervical carcinoma at earliest in developing country.

Methods: This is a prospective study of 500 women who fulfil the selection criteria. 50 pregnant patients for VIA (Visual inspection with acetic acid), 50 pregnant patients for VILI (Visual inspection with lugol’s iodine) and 400 non-pregnant women for VIA, VILI and colposcopy were enrolled. In positive cases, cervical biopsy with histopathological examination was done. The sensitivity, specificity and positive predictive value of each test were obtained and compared. Chi-square (X2) test was used to test the significance of difference between two proportions of a quantitative data.

Results: The sensitivity, specificity, positive predictive value and negative predictive value for VIA (85.1%, 84.1%, 41.7%, 97%), VILI (95.7%, 92.4%, 62.5%, 93.4%) and Colposcopy (83%, 86%, 51.3%, 96.6%) were statistically significant with its histopathological report.

Conclusions: In a poor developing country like India where pap smear and colposcopy is not available in low resource setting VIA and VILI can prove a very helpful tool in picking up abnormal looking cervix which can then be confirmed by pap or colposcopy. It will go a long way in reducing the incidence of cervical carcinoma.

References

Singh V, Sehgal A, Parashari A, Sodhani P, Satyanarayana L. Early detection of cervical cancer through acetic application: an aided visual inspection. Singapore Med J. 2001;42(8):351-4.

Ferreccio C, Gage J. Visual inspection of the uterine cervix with Acetic Acid (VIA): a critical review and selected articles. Pan American Health Organization; 2003.

Ghosh P, Gandhi G, Kochhar PK, Zutshi V, Batra S. Visual inspection of cervix with Lugol’s iodine for detection of premalignant and malignant lesions of cervix. Indian J Med Res. 2012;136(2):265-271.

Denny L. Cervical cancer: prevention and treatment. Discov Med. 2012;14:125-131.

Dinshaw KA, Shastri SS. Screening for cervical cancer in India. Natl Med J India. 2001;14:1.

Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ. 2005 Mar;83(3):186-94.

Miller AB, Sankaranarayanan R, Bosch FX, Sepulveda C. Can screening for cervical cancer be improved, especially in developing countries? Int J Cancer. 2033;107:337-40.

Rana T, Zia A, Sher S, Tariq S, Asghar F. Comparative evaluation of Pap smear and visual inspection of acetic acid (VIA) in cervical cancer screening program in Lady Willingdon Hospital, Lahore. Annal King Edward Med Univ. 2010;16(1 SI).

Bhattacharyya AK, Nath JD, Deka H. Comparative study between pap smear and visual inspection with acetic acid (via) in screening of CIN and early cervical cancer. J Midlife Health. 2015 April-June;6(2):53-5.

Sedlis A, Sall S, Tsukada Y, Park R, Mangan C, Shingleton H et al. Micro-invasive carcinoma of the uterine cervix: a clinical pathologic study. Am J Obstet Gynecol. 1979;133(1):6474.

Sonali D, Kanan Y, Smita A, Suvarna D. Role of colposcopy using modified reid’s index in screening of cervical cancer in women with abnormal cervix on naked eye examination. J Evol Med Dental Sci. 2014;3(4):902-6.

Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res. 1973;33:1353-67.

Kvale G, Heuch I, Nilssen S. Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer. 1988;58:820-4.

Cuzick J, Sasieni P, Singer A. Risk factors for invasive cervix cancer in young women. Eur J Cancer. 1996;32A:836-41.

Segnan N. Socioeconomic status and cancer screening. IARC Sci Publ. 1997;(138):369-76.

Shankaranarayanan R, Esmy PO, Rajkumar R, Swaminathan R, Shanthakumari S, Fayette JM et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370(9585):398-406.

Aggarwal P, Batra S, Gandhi G, Zutshi V. Comparison of Papanicolaou test with visual detection tests in screening for cervical cancer and developing the optimal strategy for low resource settings. Int J Gynecol Cancer. 2010;20:862-8.

University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet. 1999;353:869-73.

Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K. Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Cancer Prevention Group. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet. 2003;361:814-20.

Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110:907-13.

Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankaranarayanan R. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet. 2010;109:100-4.

Goel A, Gandhi G, Batra S, Bhambhani S, Zutshi V, Sachdeva P. Visual inspection of the cervix with acetic acid for cervical intraepithelial lesions. Int J Gynecol Obstet. 2005;88:25-30.

Juneja A, Sehgal A, Sharma S, Pandey A. Cervical cancer screening in India: strategies revisited. Indian J Med Sci. 2007;61:34-47.

Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filhoa, Tatti S et al. Evaluation of visual inspection with acetic acid (VIA), Lugol’s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. J Med Screen. 2005;12(3):142-9.

Pothisuwan M, Pataradool K, Tangiitgamol S, Srijaipracharoen S, Manusirivithaya, Thawaramorn T. Visual inspection with acetic acid for detection of high grade lesion in atypical squamous cells and low grade squamous intraepithelial lesions from cervical Pap smear. J Gynecol Oncol. 2011;22(3)145-151.

Downloads

Published

2017-12-25

Issue

Section

Original Research Articles